MacroGenics Announces Positive Results from Phase 3 SOPHIA Study

Long

MacroGenics, Inc. (NASDAQ:MGNX)

NASDAQ:MGNX MacroGenics, Inc.

beyondta

MGNX: MacroGenics, Inc.
2019-05-15 17:07:27
MacroGenics Announces Positive Results from Phase 3 SOPHIA Study of Margetuximab in Patients with HER2-Positive Metastatic Breast Cancer - GlobeNewswire

Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.